Goodrich Katherine 4

What Happened

• Katherine Goodrich, a Tarsus Pharmaceuticals (TARS) non-employee director, had 2,954 restricted stock units (RSUs vest) converted into 2,954 shares on June 12, 2026 (transaction code M = exercise/conversion of derivative). The filing shows an immediate disposition of 2,954 shares at $0.00 (also coded M), which typically reflects shares withheld or surrendered to the company to satisfy tax withholding obligations following RSU settlement.

Key Details

• Transaction date: 2026-06-12.
• Acquired: 2,954 shares via settlement of vested RSUs (no cash price reported).
• Disposed: 2,954 shares at $0.00 (derivative disposition) — commonly indicates share withholding for taxes.
• Footnotes: RSUs were granted on 2026-06-12? (grant date per filing: June 12, 2025) and vested in full on the one-year anniversary (per F1–F3). Each RSU equals one share.
• Filing date: 2026-06-16 — filed within the Form 4 two-business-day window (timely).
• Shares owned after the transactions: not specified in the provided filing details.

Context

• This was an RSU settlement for a director, not an open-market buy or sell. The simultaneous $0.00 disposition is a routine administrative step (net/share withholding) to satisfy tax obligations and does not necessarily indicate a market-directional trade by the insider.